메뉴 건너뛰기




Volumn 96, Issue 5, 2016, Pages 461-474

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors

Author keywords

Consensus; Inhibitors; Prophylaxis; Surgery haemophilia

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; ALLOANTIBODY; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

EID: 84961724151     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12730     Document Type: Article
Times cited : (15)

References (46)
  • 1
    • 4544229639 scopus 로고    scopus 로고
    • Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
    • Abshire TC, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2004;2:899-909.
    • (2004) J Thromb Haemost , vol.2 , pp. 899-909
    • Abshire, T.C.1    Kenet, G.2
  • 2
    • 33750342991 scopus 로고    scopus 로고
    • A retrospective postlicensure survey of FEIBA efficacy and safety
    • DiMichele DM, Négrier C. A retrospective postlicensure survey of FEIBA efficacy and safety. Haemophilia 2006;12:352-62.
    • (2006) Haemophilia , vol.12 , pp. 352-362
    • DiMichele, D.M.1    Négrier, C.2
  • 3
    • 63349099323 scopus 로고    scopus 로고
    • Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors
    • Giangrande PLF, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, Dolan G, Ingerslev J. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia 2009;15:501-8.
    • (2009) Haemophilia , vol.15 , pp. 501-508
    • Giangrande, P.L.F.1    Wilde, J.T.2    Madan, B.3    Ludlam, C.A.4    Tuddenham, E.G.5    Goddard, N.J.6    Dolan, G.7    Ingerslev, J.8
  • 7
    • 0030837755 scopus 로고    scopus 로고
    • Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity
    • Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost 1997;77:1113-9.
    • (1997) Thromb Haemost , vol.77 , pp. 1113-1119
    • Negrier, C.1    Goudemand, J.2    Sultan, Y.3    Bertrand, M.4    Rothschild, C.5    Lauroua, P.6
  • 8
    • 84876814220 scopus 로고    scopus 로고
    • SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies
    • Négrier C, Lienhart A, Numerof R, Stephens D, Wong WY, Baghaei F, Yee TT. SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies. Haemophilia 2013;19:1-8.
    • (2013) Haemophilia , vol.19 , pp. 1-8
    • Négrier, C.1    Lienhart, A.2    Numerof, R.3    Stephens, D.4    Wong, W.Y.5    Baghaei, F.6    Yee, T.T.7
  • 9
    • 84863222250 scopus 로고    scopus 로고
    • ®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience
    • ®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience. Haemophilia 2012;18:544-9.
    • (2012) Haemophilia , vol.18 , pp. 544-549
    • Holmström, M.1    Tran, H.T.T.2    Holme, P.A.3
  • 10
    • 84922980244 scopus 로고    scopus 로고
    • Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay
    • Tran HTT, Sørensen B, Bjørnsen S, Pripp AH, Tjønnfjord GE, Andre Holme P. Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay. Haemophilia 2015;21:275-83.
    • (2015) Haemophilia , vol.21 , pp. 275-283
    • Tran, H.T.T.1    Sørensen, B.2    Bjørnsen, S.3    Pripp, A.H.4    Tjønnfjord, G.E.5    Andre Holme, P.6
  • 12
    • 33646246176 scopus 로고    scopus 로고
    • Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA
    • Tjønnfjord GE. Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA. Semin Hematol 2006;43(2 Suppl. 4):S18-21.
    • (2006) Semin Hematol , vol.43 , Issue.2 , pp. S18-S21
    • Tjønnfjord, G.E.1
  • 13
    • 84962775134 scopus 로고    scopus 로고
    • Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors
    • Lauroua P, Ferrer A-M, Guérin V. Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors. Haemophilia 2009;1:1-8.
    • (2009) Haemophilia , vol.1 , pp. 1-8
    • Lauroua, P.1    Ferrer, A.-M.2    Guérin, V.3
  • 14
    • 78049311744 scopus 로고    scopus 로고
    • Surgery in patients with haemophilia and high responding inhibitors: Izmir experience
    • Balkan C, Karapinar D, Aydogdu S, Ozcan C, Ay Y, Akin M, Kavakli K. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience. Haemophilia 2010;16:902-9.
    • (2010) Haemophilia , vol.16 , pp. 902-909
    • Balkan, C.1    Karapinar, D.2    Aydogdu, S.3    Ozcan, C.4    Ay, Y.5    Akin, M.6    Kavakli, K.7
  • 15
    • 84860324856 scopus 로고    scopus 로고
    • Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey
    • FEIBA Investigators Team.
    • Zülfikar B, Aydogan G, Salcioglu Z, Oner AF, Kavakli K, Gursel T, Zülfikar H; FEIBA Investigators Team.Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Haemophilia 2012;18:383-91.
    • (2012) Haemophilia , vol.18 , pp. 383-391
    • Zülfikar, B.1    Aydogan, G.2    Salcioglu, Z.3    Oner, A.F.4    Kavakli, K.5    Gursel, T.6    Zülfikar, H.7
  • 18
    • 27744516149 scopus 로고    scopus 로고
    • Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors
    • Gringeri A, Mannucci PM. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors. Haemophilia 2005;11:611-9.
    • (2005) Haemophilia , vol.11 , pp. 611-619
    • Gringeri, A.1    Mannucci, P.M.2
  • 19
    • 33750362646 scopus 로고    scopus 로고
    • Inhibitors of factor VIII: treatment of acute bleeds
    • In: Lee CA, Berntorp EE, Hoots WK, Aledor LM, eds Oxford: Blackwell Publishing Ltd
    • Negrier C. Inhibitors of factor VIII: treatment of acute bleeds. In: Lee CA, Berntorp EE, Hoots WK, Aledor LM, eds. Textbook of Hemophilia. Oxford: Blackwell Publishing Ltd; 2005:80.
    • (2005) Textbook of Hemophilia , pp. 80
    • Negrier, C.1
  • 20
    • 0037328109 scopus 로고    scopus 로고
    • Treatment of the bleeding inhibitor patient
    • Astermark J. Treatment of the bleeding inhibitor patient. Semin Thromb Hemost 2003;29:77-86.
    • (2003) Semin Thromb Hemost , vol.29 , pp. 77-86
    • Astermark, J.1
  • 21
    • 0033927502 scopus 로고    scopus 로고
    • Suggestions for the management of factor VIII inhibitors
    • Association of hemophilia clinic directors of Canada I. Suggestions for the management of factor VIII inhibitors. Haemophilia 2000;6:52-9.
    • (2000) Haemophilia , vol.6 , pp. 52-59
  • 22
    • 0032884251 scopus 로고    scopus 로고
    • Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
    • Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia 1999;5:253-9.
    • (1999) Haemophilia , vol.5 , pp. 253-259
    • Scharrer, I.1
  • 23
    • 84874061795 scopus 로고    scopus 로고
    • How to handle major surgery in inhibitor patients using factor VIII inhibitor bypass activity
    • Ingerslev J. How to handle major surgery in inhibitor patients using factor VIII inhibitor bypass activity. Haemophilia 2009;15:621.
    • (2009) Haemophilia , vol.15 , pp. 621
    • Ingerslev, J.1
  • 27
    • 11044236112 scopus 로고    scopus 로고
    • Cases of surgery in high-responder haemophilia patients
    • Goudemand J, Tagariello G, Lopaciuk F. Cases of surgery in high-responder haemophilia patients. Haemophilia 2004;10(Suppl. 2):46-9.
    • (2004) Haemophilia , vol.10 , pp. 46-49
    • Goudemand, J.1    Tagariello, G.2    Lopaciuk, F.3
  • 28
    • 34548297571 scopus 로고    scopus 로고
    • Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review
    • Kraut EH, Aledort LM, Arkin S, Stine KC, Wong WY. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review. Haemophilia 2007;13:508-17.
    • (2007) Haemophilia , vol.13 , pp. 508-517
    • Kraut, E.H.1    Aledort, L.M.2    Arkin, S.3    Stine, K.C.4    Wong, W.Y.5
  • 29
    • 34247169953 scopus 로고    scopus 로고
    • Use of FEIBA for Invasive or Surgical Procedures in patients with severe hemophilia A or B with inhibitors
    • Stine KC, Shrum D, Becton DL. Use of FEIBA for Invasive or Surgical Procedures in patients with severe hemophilia A or B with inhibitors. J Pediatr Hematol Oncol 2007;29:216-21.
    • (2007) J Pediatr Hematol Oncol , vol.29 , pp. 216-221
    • Stine, K.C.1    Shrum, D.2    Becton, D.L.3
  • 30
    • 43449093156 scopus 로고    scopus 로고
    • Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters
    • Mancuso ME, Mannucci PM, Sartori A, Agliardi A, Santagostino E. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters. Br J Haematol 2008;141:689-95.
    • (2008) Br J Haematol , vol.141 , pp. 689-695
    • Mancuso, M.E.1    Mannucci, P.M.2    Sartori, A.3    Agliardi, A.4    Santagostino, E.5
  • 31
    • 79951875993 scopus 로고    scopus 로고
    • Experience of four UK comprehensive care centres using FEIBA for surgeries in patients with inhibitors
    • Rangarajan S, Yee TT, Wilde J. Experience of four UK comprehensive care centres using FEIBA for surgeries in patients with inhibitors. Haemophilia 2011;17:28-34.
    • (2011) Haemophilia , vol.17 , pp. 28-34
    • Rangarajan, S.1    Yee, T.T.2    Wilde, J.3
  • 32
    • 84857984508 scopus 로고    scopus 로고
    • Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature
    • Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia 2011;17:910-9.
    • (2011) Haemophilia , vol.17 , pp. 910-919
    • Caviglia, H.1    Candela, M.2    Galatro, G.3    Neme, D.4    Moretti, N.5    Bianco, R.P.6
  • 33
    • 84962711897 scopus 로고    scopus 로고
    • Human medicine: NovoSeven (product information) [Internet]. London. [cited 2 July 2014]. Available from:(accessed 26 September 2015).
    • European Medicines Agency. Human medicine: NovoSeven (product information) [Internet]. London. [cited 2 July 2014]. Available from: http://www.ema.europa.eu/ema/index.jsp?curlpages/medicines/human/medicines/000074/human_med_000936.jsp%26mid=WC0b01ac058001d124 (accessed 26 September 2015).
  • 34
    • 84871011258 scopus 로고    scopus 로고
    • Guidelines for the management of haemophilia
    • Treatment Guidelines Working Group on Behalf of the World Federation of Hemophilia
    • Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al.; Treatment Guidelines Working Group on Behalf of the World Federation of Hemophilia. Guidelines for the management of haemophilia. Haemophilia 2013;19:e1-47.
    • (2013) Haemophilia , vol.19 , pp. e1-47
    • Srivastava, A.1    Brewer, A.K.2    Mauser-Bunschoten, E.P.3
  • 35
    • 0344406183 scopus 로고    scopus 로고
    • A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation
    • Ludlam CA, Smith MP, Morfini M, Gringeri A, Santagostino E, Savidge GF. A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation. Br J Haematol 2003;120:808-13.
    • (2003) Br J Haematol , vol.120 , pp. 808-813
    • Ludlam, C.A.1    Smith, M.P.2    Morfini, M.3    Gringeri, A.4    Santagostino, E.5    Savidge, G.F.6
  • 36
    • 0034813905 scopus 로고    scopus 로고
    • Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures
    • Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U. Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures. Haemophilia 2001;7:517-22.
    • (2001) Haemophilia , vol.7 , pp. 517-522
    • Cooper, H.A.1    Jones, C.P.2    Campion, E.3    Roberts, H.R.4    Hedner, U.5
  • 40
    • 73949150801 scopus 로고    scopus 로고
    • Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries
    • Aouba A, Dezamis E, Sermet A, Rothschild C, Hermine O, Lasne D, Torchet MF. Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries. Haemophilia 2010;16:54-60.
    • (2010) Haemophilia , vol.16 , pp. 54-60
    • Aouba, A.1    Dezamis, E.2    Sermet, A.3    Rothschild, C.4    Hermine, O.5    Lasne, D.6    Torchet, M.F.7
  • 41
    • 84904737231 scopus 로고    scopus 로고
    • Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen
    • Van Veen JJ, Maclean RM, Hampton KK, Hamer A, Makris M. Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen. Haemophilia 2014;20:587-92.
    • (2014) Haemophilia , vol.20 , pp. 587-592
    • Van Veen, J.J.1    Maclean, R.M.2    Hampton, K.K.3    Hamer, A.4    Makris, M.5
  • 43
    • 40449108264 scopus 로고    scopus 로고
    • Some recent developments regarding arthropathy and inhibitors in haemophilia
    • Rodriguez-Merchan EC. Some recent developments regarding arthropathy and inhibitors in haemophilia. Haemophilia 2008;14:242-7.
    • (2008) Haemophilia , vol.14 , pp. 242-247
    • Rodriguez-Merchan, E.C.1
  • 44
    • 84962779350 scopus 로고    scopus 로고
    • Surgery and invasive procedure with bypassing agents in hemophilic patients with inhibitors: a single center experience
    • Park YS, Yoon HJ. Surgery and invasive procedure with bypassing agents in hemophilic patients with inhibitors: a single center experience. Haemophilia 2014;20(Suppl. 3):43.
    • (2014) Haemophilia , vol.20 , pp. 43
    • Park, Y.S.1    Yoon, H.J.2
  • 45
    • 84859198466 scopus 로고    scopus 로고
    • Longer FVIII: the 4th generation
    • Makris M. Longer FVIII: the 4th generation. Blood 2012;119:2972-3.
    • (2012) Blood , vol.119 , pp. 2972-2973
    • Makris, M.1
  • 46
    • 84869795811 scopus 로고    scopus 로고
    • How we use recombinant activated factor VII in patients with haemophilia A or B complicated by inhibitors
    • Hematology working group.
    • Brown SA, Barnes C, Curtin J, Dunkley S, Ockelford P, Phillips J, Rowell J, Smith M, Tran H; Hematology working group. How we use recombinant activated factor VII in patients with haemophilia A or B complicated by inhibitors. Intern Med J 2012;42:1243-50.
    • (2012) Intern Med J , vol.42 , pp. 1243-1250
    • Brown, S.A.1    Barnes, C.2    Curtin, J.3    Dunkley, S.4    Ockelford, P.5    Phillips, J.6    Rowell, J.7    Smith, M.8    Tran, H.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.